Amy T. Lynch
Research Subjects
Amy T. Lynch has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Bridget Louise Stocker
School of Chemical and Physical Sciences, Victoria University of Wellington, Wellington P.O. Box 600, New Zealand
2 shared publications - Emma Marie Dangerfield
School of Chemical and Physical Sciences, Victoria University of Wellington, PO Box 600, Wellington, New Zealand
2 shared publications - Mattie Simon Maria Timmer
School of Chemical and Physical Sciences, Victoria University of Wellington, PO Box 600, Wellington, New Zealand
2 shared publications Amy J. Foster
School of Chemical and Physical Sciences
1 shared publicationBenjamin Bridgeman
AgResearch, Hopkirk Research Institute, Palmerston North, New Zealand
1 shared publicationBridget L. Stocker
School of Chemical and Physical Sciences
1 shared publication
Latest Publications
- 4 February 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (6) , 1385-1389
The Synthesis of Glycosyl Amides from Unprotected Carbohydrates and Acylsilanes
We report on a new methodology for the stereoselective synthesis of β-anomeric N-glycosyl amides from unprotected carbohydrates via the reaction of in situ generated carbohydrate oximes with acylsilanes. By variation of the acylsilane, N-glycosyl amides with azide and chloride conjugation handles are prepared in excellent yield and β-selectivity from unprotected sugars.
- 4 February 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (6) , 1385-1389
The Synthesis of Glycosyl Amides from Unprotected Carbohydrates and Acylsilanes
We report on a new methodology for the stereoselective synthesis of β-anomeric N-glycosyl amides from unprotected carbohydrates via the reaction of in situ generated carbohydrate oximes with acylsilanes. By variation of the acylsilane, N-glycosyl amides with azide and chloride conjugation handles are prepared in excellent yield and β-selectivity from unprotected sugars.
- Open Access
- 19 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0278853
The trehalose glycolipid C18Brar promotes antibody and T-cell immune responses to Mannheimia haemolytica and Mycoplasma ovipneumoniae whole cell antigens in sheep
Bronchopneumonia is a common respiratory disease in livestock.Mannheimia haemolyticais considered the main causative pathogen leading to lung damage in sheep, withMycoplasma ovipneumoniaeand ParaInfluenza virus type 3, combined with adverse physical and physiological stress, being predisposing factors. A balance of humoral and cellular immunity is thought to be important for protection against developing respiratory disease. In the current study, we compared the ability of the trehalose glycolipid adjuvant C18Brar (C18-alkylated brartemicin analogue) and three commercially available adjuvant systemsi.e., Quil-A, Emulsigen-D, and a combination of Quil-A and aluminium hydroxide gel, to stimulate antibody and cellular immune responses to antigens from inactivated whole cells ofM.haemolyticaandM.ovipneumoniaein sheep. C18Brar and Emulsigen-D induced the strongest antigen-specific antibody responses to bothM.haemolyticaandM.ovipneumoniae, while C18Brar and Quil-A promoted the strongest antigen-specific IL-17A responses. The expression of genes with known immune functions was determined in antigen-stimulated blood cultures using Nanostring nCounter technology. The expression levels ofCD40,IL22,TGFB1, andIL2RAwere upregulated in antigen-stimulated blood cultures from animals vaccinated with C18Brar, which is consistent with T-cell activation. Collectively, the results demonstrate that C18Brar can promote both antibody and cellular responses, notably Th17 immune responses in a ruminant species.
- 19 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0278853
Open AccessThe trehalose glycolipid C18Brar promotes antibody and T-cell immune responses to Mannheimia haemolytica and Mycoplasma ovipneumoniae whole cell antigens in sheep
Bronchopneumonia is a common respiratory disease in livestock.Mannheimia haemolyticais considered the main causative pathogen leading to lung damage in sheep, withMycoplasma ovipneumoniaeand ParaInfluenza virus type 3, combined with adverse physical and physiological stress, being predisposing factors. A balance of humoral and cellular immunity is thought to be important for protection against developing respiratory disease. In the current study, we compared the ability of the trehalose glycolipid adjuvant C18Brar (C18-alkylated brartemicin analogue) and three commercially available adjuvant systemsi.e., Quil-A, Emulsigen-D, and a combination of Quil-A and aluminium hydroxide gel, to stimulate antibody and cellular immune responses to antigens from inactivated whole cells ofM.haemolyticaandM.ovipneumoniaein sheep. C18Brar and Emulsigen-D induced the strongest antigen-specific antibody responses to bothM.haemolyticaandM.ovipneumoniae, while C18Brar and Quil-A promoted the strongest antigen-specific IL-17A responses. The expression of genes with known immune functions was determined in antigen-stimulated blood cultures using Nanostring nCounter technology. The expression levels ofCD40,IL22,TGFB1, andIL2RAwere upregulated in antigen-stimulated blood cultures from animals vaccinated with C18Brar, which is consistent with T-cell activation. Collectively, the results demonstrate that C18Brar can promote both antibody and cellular responses, notably Th17 immune responses in a ruminant species.
- 29 October 2021
- Published by Elsevier in Carbohydrate Research
- Vol. 511, 108461
Amide-linked brartemicin glycolipids exhibit Mincle-mediated agonist activity in vitro
- 29 October 2021
- Published by Elsevier in Carbohydrate Research
- Vol. 511, 108461
Amide-linked brartemicin glycolipids exhibit Mincle-mediated agonist activity in vitro